Cargando…

The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach

AIMS: Cathepsin D is a ubiquitous lysosomal protease that is primarily secreted due to oxidative stress. The role of circulating cathepsin D in heart failure (HF) is unknown. The aim of this study is to determine the association between circulating cathepsin D levels and clinical outcomes in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoes, Martijn F., Tromp, Jasper, Ouwerkerk, Wouter, Bomer, Nils, Oberdorf‐Maass, Silke U., Samani, Nilesh J., Ng, Leong L., Lang, Chim C., van der Harst, Pim, Hillege, Hans, Anker, Stefan D., Metra, Marco, van Veldhuisen, Dirk J., Voors, Adriaan A., van der Meer, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754332/
https://www.ncbi.nlm.nih.gov/pubmed/31797504
http://dx.doi.org/10.1002/ejhf.1674
_version_ 1783626170639581184
author Hoes, Martijn F.
Tromp, Jasper
Ouwerkerk, Wouter
Bomer, Nils
Oberdorf‐Maass, Silke U.
Samani, Nilesh J.
Ng, Leong L.
Lang, Chim C.
van der Harst, Pim
Hillege, Hans
Anker, Stefan D.
Metra, Marco
van Veldhuisen, Dirk J.
Voors, Adriaan A.
van der Meer, Peter
author_facet Hoes, Martijn F.
Tromp, Jasper
Ouwerkerk, Wouter
Bomer, Nils
Oberdorf‐Maass, Silke U.
Samani, Nilesh J.
Ng, Leong L.
Lang, Chim C.
van der Harst, Pim
Hillege, Hans
Anker, Stefan D.
Metra, Marco
van Veldhuisen, Dirk J.
Voors, Adriaan A.
van der Meer, Peter
author_sort Hoes, Martijn F.
collection PubMed
description AIMS: Cathepsin D is a ubiquitous lysosomal protease that is primarily secreted due to oxidative stress. The role of circulating cathepsin D in heart failure (HF) is unknown. The aim of this study is to determine the association between circulating cathepsin D levels and clinical outcomes in patients with HF and to investigate the biological settings that induce the release of cathepsin D in HF. METHODS AND RESULTS: Cathepsin D levels were studied in 2174 patients with HF from the BIOSTAT‐CHF index study. Results were validated in 1700 HF patients from the BIOSTAT‐CHF validation cohort. The primary combined outcome was all‐cause mortality and/or HF hospitalizations. Human pluripotent stem cell‐derived cardiomyocytes were subjected to hypoxic, pro‐inflammatory signalling and stretch conditions. Additionally, cathepsin D expression was inhibited by targeted short hairpin RNAs (shRNA). Higher levels of cathepsin D were independently associated with diabetes mellitus, renal failure and higher levels of interleukin‐6 and N‐terminal pro‐B‐type natriuretic peptide (P < 0.001 for all). Cathepsin D levels were independently associated with the primary combined outcome [hazard ratio (HR) per standard deviation (SD): 1.12; 95% confidence interval (CI) 1.02–1.23], which was validated in an independent cohort (HR per SD: 1.23, 95% CI 1.09–1.40). In vitro experiments demonstrated that human stem cell‐derived cardiomyocytes released cathepsin D and troponin T in response to mechanical stretch. ShRNA‐mediated silencing of cathepsin D resulted in increased necrosis, abrogated autophagy, increased stress‐induced metabolism, and increased release of troponin T from human stem cell‐derived cardiomyocytes under stress. CONCLUSIONS: Circulating cathepsin D levels are associated with HF severity and poorer outcome, and reduced levels of cathepsin D may have detrimental effects with therapeutic potential in HF.
format Online
Article
Text
id pubmed-7754332
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-77543322020-12-23 The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach Hoes, Martijn F. Tromp, Jasper Ouwerkerk, Wouter Bomer, Nils Oberdorf‐Maass, Silke U. Samani, Nilesh J. Ng, Leong L. Lang, Chim C. van der Harst, Pim Hillege, Hans Anker, Stefan D. Metra, Marco van Veldhuisen, Dirk J. Voors, Adriaan A. van der Meer, Peter Eur J Heart Fail Biomarkers AIMS: Cathepsin D is a ubiquitous lysosomal protease that is primarily secreted due to oxidative stress. The role of circulating cathepsin D in heart failure (HF) is unknown. The aim of this study is to determine the association between circulating cathepsin D levels and clinical outcomes in patients with HF and to investigate the biological settings that induce the release of cathepsin D in HF. METHODS AND RESULTS: Cathepsin D levels were studied in 2174 patients with HF from the BIOSTAT‐CHF index study. Results were validated in 1700 HF patients from the BIOSTAT‐CHF validation cohort. The primary combined outcome was all‐cause mortality and/or HF hospitalizations. Human pluripotent stem cell‐derived cardiomyocytes were subjected to hypoxic, pro‐inflammatory signalling and stretch conditions. Additionally, cathepsin D expression was inhibited by targeted short hairpin RNAs (shRNA). Higher levels of cathepsin D were independently associated with diabetes mellitus, renal failure and higher levels of interleukin‐6 and N‐terminal pro‐B‐type natriuretic peptide (P < 0.001 for all). Cathepsin D levels were independently associated with the primary combined outcome [hazard ratio (HR) per standard deviation (SD): 1.12; 95% confidence interval (CI) 1.02–1.23], which was validated in an independent cohort (HR per SD: 1.23, 95% CI 1.09–1.40). In vitro experiments demonstrated that human stem cell‐derived cardiomyocytes released cathepsin D and troponin T in response to mechanical stretch. ShRNA‐mediated silencing of cathepsin D resulted in increased necrosis, abrogated autophagy, increased stress‐induced metabolism, and increased release of troponin T from human stem cell‐derived cardiomyocytes under stress. CONCLUSIONS: Circulating cathepsin D levels are associated with HF severity and poorer outcome, and reduced levels of cathepsin D may have detrimental effects with therapeutic potential in HF. John Wiley & Sons, Ltd 2019-12-03 2020-11 /pmc/articles/PMC7754332/ /pubmed/31797504 http://dx.doi.org/10.1002/ejhf.1674 Text en © 2019 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Biomarkers
Hoes, Martijn F.
Tromp, Jasper
Ouwerkerk, Wouter
Bomer, Nils
Oberdorf‐Maass, Silke U.
Samani, Nilesh J.
Ng, Leong L.
Lang, Chim C.
van der Harst, Pim
Hillege, Hans
Anker, Stefan D.
Metra, Marco
van Veldhuisen, Dirk J.
Voors, Adriaan A.
van der Meer, Peter
The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach
title The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach
title_full The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach
title_fullStr The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach
title_full_unstemmed The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach
title_short The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach
title_sort role of cathepsin d in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach
topic Biomarkers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754332/
https://www.ncbi.nlm.nih.gov/pubmed/31797504
http://dx.doi.org/10.1002/ejhf.1674
work_keys_str_mv AT hoesmartijnf theroleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT trompjasper theroleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT ouwerkerkwouter theroleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT bomernils theroleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT oberdorfmaasssilkeu theroleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT samaninileshj theroleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT ngleongl theroleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT langchimc theroleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT vanderharstpim theroleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT hillegehans theroleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT ankerstefand theroleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT metramarco theroleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT vanveldhuisendirkj theroleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT voorsadriaana theroleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT vandermeerpeter theroleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT hoesmartijnf roleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT trompjasper roleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT ouwerkerkwouter roleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT bomernils roleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT oberdorfmaasssilkeu roleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT samaninileshj roleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT ngleongl roleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT langchimc roleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT vanderharstpim roleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT hillegehans roleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT ankerstefand roleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT metramarco roleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT vanveldhuisendirkj roleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT voorsadriaana roleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach
AT vandermeerpeter roleofcathepsindinthepathophysiologyofheartfailureanditspotentiallybeneficialpropertiesatranslationalapproach